Skip to product information
1 of 1

Medical Education Hub

2023 MSK Pulmo-Oncology Symposium

2023 MSK Pulmo-Oncology Symposium

Regular price €50,00 EUR
Regular price Sale price €50,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Quantity


Friday, June 9, 2023, 8:00 AM – 6:00 PM, Online, New York, NY

Overview

Pulmo-Oncology is an emerging discipline that has great importance to the clinical care of cancer patients. The respiratory system is often impacted by direct cancer involvement, infections, and toxicities stemming from the use of anti-neoplastic agents.

Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

In this inaugural Symposium, clinical experts from Memorial Sloan Kettering (MSK) and other institutions will present an up-to-date overview of cutting-edge cancer therapies and best practice strategies in the evaluation and management of lung disease.
 The purpose of this Symposium is to provide a state-of-the-art, case-based, multidisciplinary curriculum that addresses selected topics relevant to the respiratory health of patients with cancer.

Specialties

Specialties – Bone Marrow Transplant, Cardiology, Emergency Medicine, General and Family Practice, Geriatric Medicine, Hematology, Hospice and Palliative Medicine, Hospitalist, Immunotherapy, Infectious Diseases, Integrative Medicine, Internal Medicine, Leukemia, Lymphoma, Medical Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Pharmacology and Medication Management, Physician Assistant, Pulmonary Medicine, Pulmonology, Radiation Oncology, Respiratory Therapy, Sleep Medicine, Solid Tumor Oncology, Surgical Oncology, Thoracic Medical Oncology, Thoracic Surgery
Who Should Attend

This Symposium is designed for healthcare professionals in pulmonology, hematology and oncology, and other disciplines involved in the care of cancer patients or who have a special interest in this area.
Objectives
  1. Explain the role of pulmonologist in diagnosis and management of lung cancer
  2. Identify state of the art treatment strategies for management of lung cancer and check point inhibitor pneumonitis
  3. Implement strategies for diagnosis and management of infectious and non infectious complications of stem cell transplant
  4. Implement approaches to symptom management of cough and malignant pleural effusion related dyspnea
  5. Explain clinical significance of interstitial lung abnormalities and pulmonary fibrosis in lung cancer management

 

 Topics:
  • CASE-BASED PANEL DISCUSSION- Intractable Cough Management in Cancer Patients.mp4
    Idiopathic Pulmonary Fibrosis (IPF) and Lung Cancer Surgery.mp4
    Idiopathic Pulmonary Fibrosis (IPF) and Lung Cancer Surgery.pdf
    Idiopathic Pulmonary Fibrosis (IPF) and Non-Surgical Lung Cancer Therapies.mp4
    Idiopathic Pulmonary Fibrosis (IPF) and Non-Surgical Lung Cancer Therapies.pdf
    Immune Checkpoint Inhibitor Pneumonitis- A Pulmonologist’s Perspective.mp4
    Immune Checkpoint Inhibitor Pneumonitis- A Pulmonologist’s Perspective.pdf
    Interstitial Lung Abnormality (ILA).mp4
    Interstitial Lung Abnormality (ILA).pdf
    Intractable Cough in Cancer Patients.mp4
    Intractable Cough in Cancer Patients.pdf
    Keep it Cool- Bronchoscopic CryoCore Biopsies in the Oncologic Patient Population.mp4
    Keep it Cool- Bronchoscopic CryoCore Biopsies in the Oncologic Patient Population.pdf
    Management of Malignant Pleural Effusions.mp4
    Management of Malignant Pleural Effusions.pdf
    Management of Refractory Immune Checkpoint Inhibitor Pneumonitis- A Rheumatologist’s Perspective.mp4
    Management of Refractory Immune Checkpoint Inhibitor Pneumonitis- A Rheumatologist’s Perspective.pdf
    Pulmo-Oncology_2023_Brochure.pdf
    Pulmonary Graft vs Host Disease (GVHD)- Management, Limitations and Future Directions.mp4
    Pulmonary Graft vs Host Disease (GVHD)- Management, Limitations and Future Directions.pdf
    Rechallenging Immune Checkpoint Inhibition After irAEs- Brave or Unwise..mp4
    Rechallenging Immune Checkpoint Inhibition After irAEs- Brave or Unwise..pdf
    Respiratory Infections In Transplant Cellular Therapy Recipients in The Era of Molecular Diagnostics.mp4
    Respiratory Infections In Transplant Cellular Therapy Recipients in The Era of Molecular Diagnostics.pdf
    Role of Pulmonologist in Diagnosis and Management of Lung Cancer.mp4
    Role of Pulmonologist in Diagnosis and Management of Lung Cancer.pdf
    Targeted and Immunologic Therapies for Lung cancer.mp4
    Targeted and Immunologic Therapies for Lung cancer.pdf
View full details